BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

931 related articles for article (PubMed ID: 9028794)

  • 1. Melanotropic peptide receptors: membrane markers of human melanoma cells.
    Jiang J; Sharma SD; Fink JL; Hadley ME; Hruby VJ
    Exp Dermatol; 1996 Dec; 5(6):325-33. PubMed ID: 9028794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilize conjugated melanotropins for the earlier diagnosis and treatment of melanoma.
    Cai M; Liu Z; Qu H; Fan H; Zheng Z; Hruby VJ
    Eur J Pharmacol; 2011 Jun; 660(1):188-93. PubMed ID: 21315067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspective on allogeneic melanoma lysates in active specific immunotherapy.
    Mitchell MS
    Semin Oncol; 1998 Dec; 25(6):623-35. PubMed ID: 9865677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological aspects of melanomas [proceedings].
    The TH; de Gast GC; Huiges HA; Schraffordt Koops H
    Ophthalmologica; 1977; 175(1):25-7. PubMed ID: 904885
    [No Abstract]   [Full Text] [Related]  

  • 5. CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds.
    Fargnoli MC; Chimenti S; Keller G; Soyer HP; Dal Pozzo V; Höfler H; Peris K
    J Invest Dermatol; 1998 Dec; 111(6):1202-6. PubMed ID: 9856841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of recombinant adeno-associated viral vectors for the transduction of epithelial tumor cells.
    Hoerer M; Bogedain C; Scheer U; Heberger C; Steyrer S; Burger A; Maass G
    Int J Immunopharmacol; 1997; 19(9-10):473-9. PubMed ID: 9637341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural and immunohistochemical observations concerning laminin in B16 melanoma. Is an amorphous form of laminin promoting a non hematogenous migration of tumor cells?
    Lugassy C; Christensen L; Le Charpentier M; Faure E; Escande JP
    J Submicrosc Cytol Pathol; 1998 Jan; 30(1):137-44. PubMed ID: 9530861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of human fibroblasts to tissue macrophages by the Snyder-Theilen feline sarcoma virus (ST:FeSV): growth modulation of human tumor cell lines in agar.
    Wesseling B; Kopelovich L
    Anticancer Res; 1997; 17(4A):2599-602. PubMed ID: 9252687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperdynamic hemodynamics following high-dose interleukin 2-interferon alpha therapy in patients with metastatic renal cell carcinoma. Immunotherapy as a clinical sepsis model?].
    Finck-Seelen ; Lampert R; Brandt L
    Anaesthesist; 1996 Dec; 45(12):1171-8. PubMed ID: 9065251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. l-Dopa methyl ester as a new antitumour agent.
    Wick MM
    Nature; 1977 Oct; 269(5628):512-3. PubMed ID: 909598
    [No Abstract]   [Full Text] [Related]  

  • 11. Ovarian small cell tumors: an electron microscopic review.
    Dickersin GR; Scully RE
    Ultrastruct Pathol; 1998; 22(3):199-226. PubMed ID: 9793201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic node dissections in malignant melanoma.
    Karakousis CP
    Ann Surg Oncol; 1998 Sep; 5(6):473-82. PubMed ID: 9754754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric antibodies with specificity for tumor antigens: demonstration of in situ localization to tumors after antibody therapy.
    Saleh MN; Tilden AB; Meredith RF; LoBuglio AF; Grizzle WE
    Biotech Histochem; 1998 Jul; 73(4):186-97. PubMed ID: 9735877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of hepatocyte growth factor/scatter factor on the metastatic phenotype of B16 melanoma cells.
    Rusciano D; Lin S; Lorenzoni P; Casella N; Burger MM
    Tumour Biol; 1998; 19(5):335-45. PubMed ID: 9701724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary experience with high-dose cisplatin, reduced glutathione and natural interferon-alpha in dacarbazine-resistant malignant melanoma.
    Bajetta E; Rimassa L; Carnaghi C; Del Vecchio M; Celio L; Cassata A
    Tumori; 1998; 84(1):48-51. PubMed ID: 9619714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of targeted chemoradiotherapy for malignant melanoma by exploitation of metabolic pathway].
    Jimbow K
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):105-10. PubMed ID: 9612704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells.
    Nestle FO; Alijagic S; Gilliet M; Sun Y; Grabbe S; Dummer R; Burg G; Schadendorf D
    Nat Med; 1998 Mar; 4(3):328-32. PubMed ID: 9500607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell shocked.
    Sikorski R; Peters R
    Science; 1997 Dec; 278(5346):2143, 2145. PubMed ID: 9432724
    [No Abstract]   [Full Text] [Related]  

  • 19. Fine needle aspiration biopsy of metastatic malignant melanoma with "rhabdoid" features. Frequency, cytologic features, pitfalls and ancillary studies.
    Slagel DD; Raab SS; Silverman JF
    Acta Cytol; 1997; 41(5):1426-30. PubMed ID: 9334131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent melanoma of the leg and polypoid lesions of the gallbladder--a management dilemma.
    Gould SW; Banwell PE; Rosin RD
    Eur J Surg Oncol; 1997 Aug; 23(4):368-9. PubMed ID: 9315071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.